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Integrin αv is necessary for generation of human epidermis
EJ Kennedy and TW Ridky Dermatology, University of Pennsylvania Perelman School of 
Medicine, Philadelphia, PA
Integrin subunits play crucial roles in epithelial adhesion, proliferation, differentiation and wound 
healing. However, the roles of many of the 26 integrin subunits in epidermis have not been deter-
mined. We designed a multiplexed screening approach to define roles for each member of the 
integrin family in human skin using 3-dimensional in vitro organotypic and in vivo xenograft 
skin models. In this screen, we transduced individual populations of human keratinocytes with 
shRNAs against each integrin subunit. We then quantitatively determined the fitness of each cell 
population in reconstituted human skin. This screen identified the integrin αv class of heterodimers 
as essential for generation of human skin tissue: the population of keratinocytes lacking αv was 
selected against 125-fold compared to non-silencing control cells (p<0.001). An identical screen in 
human melanocytes showed no change in fitness upon loss of integrin αv, indicating cell-intrinsic 
functions for this subunit. Loss of integrin αv alone in keratinocytes leads to cell cycle arrest with a 
2.5-fold increase in the G1/S ratio and a 3-fold increase in the G2/G1 ratio, indicating arrest at two 
cell cycle checkpoints. This cell cycle arrest is associated with significant up-regulation of p27 and 
down-regulation of p27’s E3 ubiquitin ligase, Skp2. Knock down of integrin αv in keratinocytes also 
leads to decreased activity of several growth factor signaling pathways, including phospho-EGFR, 
phospho-FAK and phospho-c-jun. Loss of integrin αv in keratinocytes leads to prevention of skin 
tissue formation in organotypic culture, and a significant decrease in ki67 positivity and BrdU 
uptake. In vivo, integrin αv knock down causes tissue graft failure. These effects are dependent 
on integrin αv’s binding partners β5 and β6, but not β8. In sum, we have used a novel screening 
approach to identify a class of integrin heterodimers—integrins αvβ5 and αvβ6—that are essential 
for skin tissue generation and proliferation.    
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An in vitro method for identifying agents with lipofilling-like activity: Assessment of lipid 
accumulation, tissue source, age and gene expression
DG Kern,1 J Namkoong,1 HE Knaggs,1 R Gopaul,1 D Bevis,4 RE Kilkuskie,4 EA Lehigh,2 
AJ Langerveld2 and WP Pfund3 1 Center for Anti-Aging Research, Nu Skin Enterprises, Inc., 
Provo, UT, 2 Genemarkers, LLC, Portage, MI, 3 Reach LifeScience Consulting, LLC, Portage, 
MI and 4 Michigan High Throughput Screening Center, Kalamazoo, MI
An in vitro assay was developed to facilitate the identification and characterization of agents demon-
strating lipofilling-like activity. The method involves exposing replicate cultures of primary human 
pre-adipocytes, obtained from assorted anatomical sites and subject ages, to various concentrations 
of test agents during cell differentiation. The cultures are then divided into groups for analysis of lipid 
accumulation using AdipoRed, cell viability using Cell Titer Blue, and collection of RNA for gene 
expression analysis. 152 target genes with several housekeeping genes were analyzed using Taqman 
real-time qPCR methods using validated Taqman gene expression assays in an OpenArray format. 
The effect of three cosmetic ingredients purported to enhance lipid accumulation in adipocytes was 
evaluated and compared to a positive control represented by a PPAR-gamma agonist. None of the 
ingredients or vehicle controls differed significantly from each other with overall responses highly 
dependent on the anatomical location for the source of the pre-adipocytes. Lipid production in 
PPAR-gamma treated adipocytes was approximately twice or more that of any cosmetic ingredient 
or vehicle control. In addition, OpenArray analysis revealed that approximately 50% of the genes 
screened were modulated with expression patterns generally consistent with lipid production. The 
method described here represents a valuable continuation of work towards developing a reliable 
and high-throughput in-vitro screening method for identifying and characterizing compounds with 
lipofilling-like activity.    
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Robust human dermal fibroblast growth and matrix production requires exposure of cryptic 
residues in the first type III repeat of fibronectin
F Lin,2 J Ward,2 J Zhu3 and RA Clark1,2 1 Dermatology, SBU, Stony Brook, NY, 2 Biomedical 
Engineering, SBU, Stony Brook, NY and 3 Biochemistry, SBU, Stony Brook, NY
Fibronectin (FN), an extracellular matrix protein requisite for tissue cell migration and collagen 
deposition and thereby necessary for embryogenesis, morphogenesis and wound healing, contains 
15 immunoglobulin-sandwich β-pleated-sheets (FNIII1-15) that contain non-exposed (cryptic), 
bioactive sites. When tissue cells, such as fibroblasts, synthesize and secrete FN they deposit most 
of the protein in fibrillar form. However, this necessitates that the cells generate sufficient traction 
forces on FN to extend the immunoglobulin-sandwich β-pleated-sheets exposing cryptic sites in 
FNIII1 and FNIII10 that are required for fibrillogenesis. Recently our team of researchers discovered 
a 14-residue peptide, P12, that binds platelet-derived growth factor-BB (PDGF-BB) and promotes 
survival, growth and migration of fibroblasts in the context of PDGF-BB in vitro and survival of 
interstitial cells after burn injury in vivo (JID, in press). By structural analysis, P12 was predicted 
to reside within FNIII1 as a cryptic peptide. Recently, we have demonstrated that this theoretical 
supposition was supported by immunological detection of P12 within FNIII1 fragments that had 
open β-pleated sheet structures. In addition, cultured young human adult dermal fibroblasts were 
found to exert sufficient tension on pericellular FN fibrils to open FNIII1 immunoglobulin-sandwich 
β-pleated sheets and thereby expose P12 as judged by an immunofluorescence Quantum-dot assays. 
In contrast fibroblasts from elderly individuals generated insufficient tension to expose P12, grew 
poorly in response to PDGR-BB and deposited little FN matrix. P12 peptide addition to culture 
medium restored the ability of fibroblasts from the elderly to growth as well as young cells and to 
deposit normal FN matrix. These results suggest that P12 may enhance the rate of wound healing 
in elderly individuals.    
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Anti-aging effect of dedifferentiated Argania spinosa cells on dermal fibroblasts cultured on 
MMP-1 damaged collagen
P Bogdanowicz, M Haure, N Steward, T Nguyen, N Castex-Rizzi and S Bessou-Touya Pierre 
Fabre Dermo-Cosmetique, Toulouse, France
Composition and mechanical properties of the dermis change dramatically as a function of age. 
Fisher et al (Am J Pathol, 2009) have postulated that the age-dependent collagen fragmentation 
alters mechanical tension or oxidative stress, which promotes expression of Matrix Metallopro-
teinase-1 (MMP-1). The aim of this study was to evaluate the capacity of Argania cell extract to 
reduce this self-perpetuating cycle, which is a critical mechanism of human skin aging. Argania 
cell extract was obtained from plant cell culture of Argania spinosa in a wave reactor, filtered and 
lyophilized. Collagen gel was partially fragmented using MMP-1. Fragmentation was visualized 
by SDS-PAGE electrophoresis and scanning electron microscopy (SEM). Fibroblasts were seeded 
onto the fragmented gel with or without Argania cell extract. After 48 hours, mRNA expression 
was quantified by RT-PCR. Type I Collagen neo-synthesis was quantified with an ELISA kit. SEM 
and SDS-PAGE electrophoresis showed that MMP-1 caused alterations in the structure of collagen 
fibrils, which is similar to aged skin. After 48 hours, mRNA levels of decorin (DCN), lumican (LUM) 
and Extracellular matrix protein 1 (ECM1) were reduced, respectively, by 32, 60 and 50%, when 
fibroblasts were cultured onto fragmented collagen. We have also showed that Argania cell extract 
increased expression of DCN (159%), LUM (558%) and ECM1 (641%). Furthermore, it induced a 
stimulation of type I collagen synthesis (38%) in normal fibroblasts. Our results demonstrated that 
Argania cell extract is able to increase collagen synthesis and expression of DCN and LUM, two 
proteoglycans decreased in aged skin. DCN and LUM bind to type I collagen and strengthens its 
assembly. Moreover, Argania cell extract strongly increased ECM1 expression which is expressed 
in dermo epidermal junction and decreased in aged skin. Argania cell extract could increase type 
I collagen synthesis and could improve its organisation, by increasing DCN and LUM expression 
and could strengthen DEJ by increasing ECM1 expression.    
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Epidermal hyperplasia observed in psoriasis vulgaris may involve expansive growth of kera-
tinocytes: Possible role of CD44, Syndecan-1 and versican
E Arciniegas,1,2 LM Carrillo,2 E Paez,2 H Rojas3 and R Ramirez2 1 Instituto de Biomedicina, 
UCV, Caracas, Venezuela, Bolivarian Republic of, 2 Servicio Autonomo Instituto de 
Biomedicina, Caracas, Venezuela, Bolivarian Republic of and 3 Instituto de Inmunologia, 
UCV, Caracas, Venezuela, Bolivarian Republic of
Tumor necrosis factor alpha (TNFα) is considered a key mediator in the pathogenesis of psoriasis. 
It stimulates the motility or migration of human keratinocytes. A mode of collective cell migration 
is the expansive growth where group of proliferative cells passively interact with each other across 
an extracellular matrix (ECM) scaffold, changing the position and maintaining cell-cell contacts 
or junctions. Here, we examined using laser scanning confocal microscopy (LSCM) whether the 
epidermal thickening in psoriasis vulgaris may involve the expansive growth of epidermal keratino-
cytes, in terms of their morphology, organization and orientation. We also investigated the presence 
and localization of the cell surface proteoglycans CD44 and syndecan-1 and the ECM component 
versican as it has been shown that these molecules seem to be regulated by proinflammatory cyto-
kines such as TNFα and that they mediate cell proliferation, differentiation, cell-cell adhesion and 
motility. Histological analysis of 7 biopsies of patients diagnosed with psoriasis vulgaris showed that 
keratinocytes were organized as a cohesive multicellular group oriented toward papillary dermis 
and maintained together by means of intercellular junctions. LSCM stacks serial sections in Z axis of 
epidermis revealed that CD44 and syndecan-1, in addition to being localized in the membrane and 
intercellular junction of basal and suprabasal cells, were also localized at the apical surface of these 
cells, whereas versican was localized in the extracellular space between cells.These observations 
suggest that the epidermal thickening in psoriatic plaques in addition to involve the proliferation of 
some basal and suprabasal keratinocytes, also would involve the expansive growth of these cells 
where CD44, syndecan1 and versican seem to play a crucial role    
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Presence of MUC1 in the epidermal thickening in psoriasis vulgaris
LM Carrillo,1 E Arciniegas,1,2 E Paez,1 E Reales,1 M Chopite,1 H Rojas3 and R Ramirez1 1 
Servicio Autonomo Instituto de Biomedicina, Caracas, Venezuela, Bolivarian Republic of, 2 
Instituto de Biomedicina, UCV, Caracas, Venezuela, Bolivarian Republic of and 3 Instituto 
de Inmunologia, UCV, Caracas, Venezuela, Bolivarian Republic of
Epidermal hyperplasia due to keratinocyte hyperproliferation is a major characteristic of psoriasis 
vulgaris. In this inflammatory skin disease, tumor necrosis factor alpha (TNFα) is found in elevated 
levels. Binding of TNFα to TNFR1 causes the activation of nuclear factor kappa B (NFκB) pathway 
which is responsible for the transcription of several genes that affect the epidermal keratinocyte 
behavior. MUC1 is a transmembranal glycoprotein that protects epithelial cells from injury caused 
by external stimuli. In addition to this role, MUC1 is involved in cell-cell adhesion, cell prolifera-
tion, motility, invasion and survival. In epithelial cells, MUC1 expression is regulated by binding 
of TNFα to TNFR1 and activation of the NFκB pathway. In human skin, MUC1 is not expressed 
by keratinocytes of normal epidermis but can be expressed by these cells in pre-malignant and 
malignant conditions. Nonetheless, the expression of MUC1 as well as its possible role in psoriasis 
vulgaris has not been considered. Here, we show that MUC1 was present in the epidermal thickening 
observed in 11 biopsies of patients diagnosed with psoriasis vulgaris which were compared with 5 
normal skin biopsies. Interestingly, MUC1 in addition to being localized at the apical surface of some 
suprabasal keratinocytes, was also localized over the entire cell surface of some of these cells and 
of some basal keratinocytes. In contrast, no MUC1 immunoreactivity was detected in the epidermis 
of normal skin. Additionally, we demonstrated that activated TNFR1, c-Src, IKKα,β and p50/p65 
were present in the epidermal thickening observed when some of these biopsies were examined. 
This study demonstrates the presence of MUC1 in psoriatic epidermal hyperplasia and suggests a 
possible role for MUC1 during the proliferation, migration and survival of human keratinocytes, 
where activated TNFR1, c-Src and NFκB seem to be required    
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Targeting Fyn in Ras-transformed cells induces F-Actin to promote adherens junction-me-
diated cell-cell adhesion
S Fenton, KA Hutchens and M Denning Pathology, Loyola University Chicago, Maywood, IL
Fyn, a member of the Src family kinases (SFK), is an oncogene in murine epidermis and is associated 
with cell-cell adhesion turnover and cell migration. Additionally, Fyn is upregulated in multiple 
tumor types, including squamous cell carcinoma (SCC). Introduction of active H-Ras(G12V) into 
the HaCaT human keratinocyte cell line resulted in upregulation of Fyn mRNA (200-fold) and pro-
tein, but did not alter the expression of other SFKs. Transduction of active Ras or Fyn induced an 
epithelial-to-mesenchymal transition in HaCaT cells, including loss of E-cadherin and cytokeratin 
expression, gain of vimentin expression and reduced cell-cell adhesion. Inhibition of Fyn activ-
ity, using siRNA or the clinical SFK inhibitor Dasatinib, increased cell-cell adhesion over 6-fold 
(p<0.001) through a rapid (5-60 min.) increase in the cortical F-Actin cytoskeleton. Dasatinib did not 
induce cytokeratin expression, but induced F-Actin colocalized with the adherens junction proteins 
α-catenin, β-catenin and p120catenin, suggesting that stable adherens junctions were mediating 
the increase in cell-cell adhesion. Additionally, Dasatinib treatment significantly inhibited cell 
migration (p<0.001). Inhibition of the Rho effector kinase ROCK blocked Dasatinib-induced F-Actin 
and cell-cell adhesion (p<0.001), implicating relief of Rho GTPase inhibition as a mechanism of 
Dasatinib-induced cell-cell adhesion. The ability of Dasatinib to promote F-Actin polymerization 
was a key initiator of cell-cell adhesion, as Dasatinib-induced cell-cell adhesion could be blocked 
by Cytochalasin D (p<0.001). Conversely, inhibiting cell-cell adhesion with low Ca+2 media did 
not block Dasatinib-induced F-Actin induction. Finally, topical Dasatinib treatment immediately 
following UV exposure significantly reduced total tumor burden in the SKH1 mouse model of 
skin carcinogenesis (p<0.05). Together these results identify the promotion of actin-based cell-cell 
adhesion as a newly described mechanism of action for Dasatinib, and suggest that Fyn inhibition 
may be an effective therapeutic approach in treating SCC.    
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Stress hormone can down-regulate key extracellular matrix proteins which may negatively 
impact skin health
Y Chen, Y Zhuang and Q Zheng Bioscience, Avon Products., Suffern, NY
Skin aging is generally characterized by lines and wrinkles, altered pigmentation, and loss of skin 
tone and skin contour. Recent research proposed that psychological stress can adversely impact 
skin health by inducing inflammation and impairing barrier function. Despite intense research, 
the exact underlying mechanisms have not been fully elucidated. In this study we investigated the 
effects of stress hormone hydrocortisone on key extracellular matrix proteins in skin fibroblasts. 
Skin fibroblasts were treated with hydrocortisone for 24 hours and RNAs were extracted for gene 
array study. Cells were also stained for key extracellular matrix proteins to visualize microfibril 
networks. The results of the gene array study identified 706 genes as stress responding genes 
with 430 genes that were up-regulated and 276 genes that were down-regulated. Multiple key 
extracellular matrix proteins are decreased by stress, including Tenascin XB and collagen I, while 
MMP15 is up-regulated. More importantly, a panel of proteins that are involved in maintaining the 
elastin matrix network were all down-regulated by stress, including MAGP1 (Microfibril-associated 
glycoprotein 1). MAGP1 plays critical role in maintaining matrix architect and organization, by 
tethering and aligning the elastic fibers together with other microfibrils and several key matrix 
proteins. Immunofluorescent staining of MAGP1 in dermal fibroblast treated with hydrocortisone 
showed a reduction in MAGP1 protein level and significant disruption of ECM network. In vitro 
vascular permeability assay was also performed to demonstrate that MAGP1 functions to maintain 
blood vessel integrity. We demonstrated that through down-regulation of key extracellular matrix 
proteins by stress factors including hydrocortisone, emotional stress may compromise key dermal 
structures and contribute to signs of skin aging.    
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An alternate endocytic motif mediates VE-cadherin degradation by Kaposi’s sarcoma-asso-
ciated herpes virus
BA Nanes1,2 and AP Kowalczyk2,3 1 Graduate Program in Biochemistry, Cell, and 
Developmental Biology, Emory University, Atlanta, GA, 2 Department of Cell Biology, Emory 
University, Atlanta, GA and 3 Department of Dermatology, Emory University, Atlanta, GA
During development, wound healing, and other dynamic morphogenic events, cadherin-based 
adhesive interactions display remarkable plasticity. In the endothelium, regulated trafficking of 
VE-cadherin to and from junctions contributes to that plasticity and is thought to be important for 
vascular development and wound healing. However, inappropriate loss of VE-cadherin contributes 
to excessive inflammation and vascular leak in a variety of conditions. One such disease is Kaposi’s 
sarcoma, an endothelial-derived tumor associated with abnormal angiogenesis and caused by 
the Kaposi’s sarcoma-associated herpesvirus (KSHV). We report that KSHV overrides the normal 
regulation of VE-cadherin trafficking through expression of the ubiquitin ligase K5, which targets 
VE-cadherin for endocytosis and degradation. K5-mediated VE-cadherin endocytosis occurs through 
a mechanism distinct from constitutive VE-cadherin endocytosis, a process we previously found 
to be required for endothelial cell migration. Constitutive VE-cadherin internalization is controlled 
by a dual-function motif in the cadherin juxtamembrane domain. This motif alternatively serves as 
a binding site for p120-catenin, which stabilizes the cadherin, or as an endocytic signal, driving 
cadherin internalization. p120 binding inhibits constitutive VE-cadherin endocytosis by masking 
this endocytic signal. K5 evades this regulatory mechanism by ubiquitinating VE-cadherin at two 
lysine residues near the transmembrane region, a signal sufficient to trigger internalization of a 
cadherin mutant lacking the constitutive endocytic signal. Mutation of these lysine residues protects 
VE-cadherin from K5-mediated downregulation, but only modestly affects constitutive VE-cadherin 
endocytosis. These findings suggest that inappropriate loss of VE-cadherin in cancer and inflam-
matory diseases may be distinguished from constitutive VE-cadherin endocytosis necessary for 
normal endothelial function.    
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The 3’UTR of α6 integrin regulates α6β4 integrin expression and localization
SB Hopkinson and J Jones School of Molecular Biosciences, Washington State University, 
Pullman, WA
The α6β4 integrin heterodimer is an essential component of the hemidesmosome in skin cells and 
mediates the adhesion of basal epidermal cells to its matrix ligand laminin in the basement mem-
brane zone. The absence of α6 integrin results in blistering of the skin (junctional epidermolysis 
bullosa), a concomitant decrease in expression of its protein binding partner β4 integrin and defects 
in both cell speed and directed migration. In this study we infected α6 integrin-deficient cells with 
lentivirus encoding α6 integrin message. In keratinocytes induced to express α6 integrin message 
limited to just the α6 integrin protein coding sequence, the product of the message surprisingly 
localizes primarily to cell-cell contacts and not to cell-substratum adhesion sites. Moreover, in such 
cells there is little expression of β4 integrin and no correction of the motility defects manifested by 
parental cells. In sharp contrast, when human keratinocytes deficient in α6 integrin are infected with 
lentivirus encoding the α6 integrin protein coding sequence together with its entire 3’ untranslated 
region (UTR) of over 2kb, α6 integrin protein is found at sites of cell-matrix interaction. In addition, 
such cells exhibit normal motility and express β4 integrin. Furthermore, we have delineated the 
functionally active region of the α6 integrin 3’UTR to a 1000 kb sized fragment. In summary, our data 
indicate that the α6 integrin 3’UTR contains a zip code which targets expression of the α6 integrin 
message to sites of cell-matrix adhesion and which expedites expression of β4 integrin protein.   
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Novel evidence that SERCA activity is required for maturation and exocytic transport of newly 
synthesized desmosomal cadherins in keratinocytes: Ifor Darier’s disease
N Li, M Park, Z Liu and LA Diaz Dermatology, University of North Carolina at Chapel Hill, 
Chapel Hill, NC
Desmosomal cadherins (desmogleins and desmocollins) are Ca2+-dependent transmembrane gly-
coproteins of desmosomes that play a key role in keratinocyte cohesion. Darier’s disease (DD) 
is an autosomal dominant skin disorder caused by mutations in sarco/endoplasmic reticulum 
Ca2+-ATPase isoform 2 (SERCA2). SERCA2, the only isoform of SERCA pumps expressed in human 
keratinocytes, functions in transporting Ca2+ from the cytosol to the lumen of the endoplasmc 
reticulum (ER). A hallmark of DD is loss of desmosomal adhesion between keratinocytes of the 
skin. In this study, we examined the effects of SERCA dysfunction on desmosomal cadherins in 
cultured human keratinocytes. We found that inactivation of SERCA by two structurally distinct, 
highly specific inhibitors of SERCA, thapsigargin and cycloprazonic acid, results in electrophoretic 
mobility shifts of desmosomal cadherins on SDS-PAGE. Unlike desmosomal cadherins from control 
cells, the mobility-shifted desmosomal cadherins are soluble in Triton X-100, sensitive to proprotein 
convertase and Endo H digestions. These results demonstrate that the mobility-shifted desmosomal 
cadherins are their precursors with an uncleaved prodomain and incomplete N-glycosylations. 
Immunofluorescence (IF) staining of SERCA-inhibited cells shows impaired delivery of desmosomal 
cadherins to the cell borders following a calcium switch. Double-IF staining reveals colocalization 
of desmoglein with ER marker, demonstrating ER retention of desmosomal cadherins. These data 
suggest that the abrogation of desmosomal cadherin maturation, including terminal processing of 
N-linked oligosaccharides, cleavage of the prodomain, and titrating into an insoluble pool, is a 
consequence of ER retention. Collectively, our results provide the first evidence that SERCA activity 
is essential for exocytic transport of newly synthesized immature desmosomal cadherins from the 
ER to the Golgi, and suggest that ER retention of nascent desmosomal cadherins may be involved 
in DD pathogenesis.    
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Expression of lysyl oxidase and its isoforms, lysyl oxidase like-peptide 2 and 4, may play a 
role in keloid pathogenesis: Development of an in vivo model system
J Andrews, Q Li, HJ Chung, J Rosenbloom and J Uitto Dermatology and Cutaneous Biology, 
Jefferson Medical College, Philadelphia, PA
Keloids manifest clinically as solid papules, nodules or plaques on predilection sites posing a 
significant clinical problem in terms of effective treatment strategies. Keloids represent a localized 
cutaneous fibrotic response, histologically characterized by excessive accumulation of collagen, 
as a result of dermal injury, and this response has been shown to be governed by regulatory factors 
implicated in tissue fibrosis, including transforming growth factor-B and connective tissue growth 
factor. In this study, we sought to elucidate the role lysyl oxidase (LOX) and its constitutive isoforms, 
lysyl oxidase-like peptides 1-4 (LOX-L1-4) may play in the pathogenesis of keloids. This group of 
enzymes participates in cross-linking of collagen into polymerized fiber structures, and they have 
previously been shown to be associated with fibrotic processes. Keloid specimens were obtained 
from patients undergoing surgical excision for cosmesis, and mRNA was extracted for quantitative 
RT-PCR. The results revealed the expression of LOX, LOX-L2 and LOX-L4 in the keloid specimens. 
Next, we sought to establish and validate an animal model system for the purpose of studying keloid 
development and pathogenesis in vivo. Fibroblasts from keloid specimens were isolated via tissue 
explant culture and dynamically seeded onto poly(lactic-co-glycolic) acid scaffolds. The seeded 
scaffolds were then implanted subcutaneously onto the backs of Rag1 immunodeficient mice and 
harvested at distinct time points. Initial results indicate maintenance of expression of LOX, LOX-L2 
and LOX-L4 at 2 weeks post-implantation, validating this system as an effective in vivo model for 
the study of keloids. In addition, the expression of LOX and its isoforms, LOX-L2 and LOX-L4, may 
serve as an important regulator of the fibrotic response characteristic of keloids, and these enzymes 
may prove to be novel therapeutic targets for treatment of keloids.    
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Structural and non-structural activities of COMP in the dermis
J Schulz,1 A Niehoff,2 W Bloch,2 K Blumbach,1 M Koch,3 B Eckes1 and T Krieg1 1 
Dermatology, University of Cologne, Cologne, Germany, 2 Biomechanics, German Sport 
University, Cologne, Germany and 3 Oral Biology, University of Cologne, Cologne, Germany
The biological and functional properties of the extracellular matrix strongly depend on its compo-
sition and the specific interaction of its constituents. Cartilage Oligomeric Matrix Protein (COMP) 
has initially been described as an abundant non-collagenous protein in cartilage. We have recently 
showed that it is also present at the dermoepidermal junction and in the interstitial connective tissue 
in the dermis; we have also demonstrated that it closely interacts with the FACIT (fibril-associated 
collagen with interrupted triple helices) collagens XII and XIV and that it is a major constituent of 
anchoring plaques. We have now analyzed the distribution of COMP in the dermis in detail using 
immunohistochemistry, immunoblotting and quantitative PCR. We found it upregulated in several 
fibrotic conditions and demonstrate, using in vitro models, that COMP levels are not only regulated 
by cytokines including IL-13 and TGFβ but also by tissue stiffness and mechanical pressure. We 
directly approached the functions of COMP by studying genetic mouse models, in which COMP has 
either been ablated or conditionally overexpressed in fibroblasts in the dermis. These were analyzed 
in vivo and in vitro by studying gene expression and protein synthesis as well as applying electron 
microscopy. These studies together with binding studies using surface plasmon resonance spec-
troscopy demonstrate that COMP has an important structural role in regulating the macromolecular 
network of the matrisome in skin. It interacts with the FACIT collagens and can also modulate the 
arrangement of the dermal collagen fibrils. Furthermore the data reveal an additional unexpected 
functional activity of COMP; absence of COMP in fibroblasts resulted in grossly dilated cisternae 
of the endoplasmic reticulum. These are caused by retention of proteins including collagen XII. We 
conclude that beside its structural activities COMP interacts with collagen in the ER and contributes 
to the regulated secretion of collagen in fibroblasts.    
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Increased intracellular collagen degradation mediated by caveolae/endo180 endocytic 
machinery promotes collagen deficiency in aged human skin
Y Li, W Xia, JJ Voorhees and GJ Fisher Department of Dermatology, University of Michigan, 
Ann Arbor, MI
Normal collagen turnover involves uptake of nascent collagen microfibrils via endo180 cell surface 
receptors, followed by intracellular degradation. The role of this uptake in age-associated collagen 
loss in human dermis remains poorly understood. Analysis of fibroblasts in young (20-30 years) 
and aged (>80 years) human skin, by immunofluorescence and immunogold electron microscopy 
revealed that endo180 was localized in specific surface membrane invaginations, caveolae, in 
dermal fibroblasts. Caveolae and endo180 were 1.8-fold (n=5, p<0.05) and 2.2-fold (n=6, p<0.01) 
greater, respectively, in fibroblasts in aged compared to young skin. Caveolae were most abundant in 
fibroblasts that had lost intimate contact with the dermal extracellular matrix (ECM) due to enhanced 
fragmentation of mature collagen fibrils in aged skin. Interestingly, reduced ECM contact induces oxi-
dative stress, a key feature of the aging process. In human skin fibroblasts, oxidant exposure elevated 
caveolae and caveolin-1 protein 2.5-fold (n=4, p<0.05) and 2.6-fold (n=6, p<0.01), respectively. 
Caveolae-mediated endocytosis was 1.5-fold (n=6, p<0.01) greater in fibroblasts in aged vs. young 
skin, measured by flow cytometry and immunostaining of caveolae-selective cargo. In addition, 
expression of CD68, a marker for endocytic activity, was increased 3.2-fold (n=6, p<0.05) in fibro-
blasts in aged compared to young skin. Collectively, the data support the concept of a self-sustaining 
cycle that involves ECM fragmentation leading to reduced fibroblast-ECM contact, which elevates 
caveolae/endo180-mediated intracellular degradation of nascent collagen microfibrils. This deg-
radation reduces incorporation of nascent microfibrils into mature collagen fibrils, thereby further 
impairing fibroblast-ECM interactions, and promoting further intracellular degradation of nascent 
collagen microfibrils. Targeting caveolae/endo180 endocytic machinery holds promise to prevent 
and reverse age-related collagen deficiency, thereby improving skin function and appearance.   
492
Use of a 3D model of aged dermis for elucidation of skin rejuvenation pathways
M Guelakis, H Meldrum and J Lee R&D, Unilever, Trumbull, CT
During the aging process, microscopic alterations in the functionality of the cellular as well as 
extracellular matrix components of the skin result in dermal phenotypes macroscopically denoted 
by wrinkles, fine lines, and sagging. Thus, a major area of study in the skin rejuvenation field focuses 
on elucidation of the cellular signalling pathways which are modulated in aged skin, or in in vitro 
paradigms of aged skin. Here, we report the use of an in vitro 3D model of aged dermis, based 
on modification of the extracellular matrix proteins of the scaffold, for the elucidation of cellular 
pathways and behaviours which may be differentially regulated with aging. We will show the 
effects of modified matrix to the dermal fibroblasts embedded within, and discuss potential routes 
to modulate this interaction between matrix and fibroblast cells.    
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Retinoic acid prevents human keratinocytes from cellular senescence via regulating IGFBP-6
H Choi, J Lee, J Lee and H Lee Amorepacific Co.,LTD, Yongin, Republic of Korea
Skin aging can be modulated by internal and external factors. Human epidermis is the first defense 
barrier against UV irradiation and oxidative stress. Stress-induced premature senescence of keratino-
cyte is a good experimental model for epidermal aging. Oxidative stress induces cellular senescence 
in normal human epidermal keratinocytes (NHKs). Insulin-like growth factor binding protein-6 
(IGFBP-6) belongs to the family of six high affinity IGF binding proteins, and shows preferential 
binding affinity for IGF-II relative to IGF-I. It was reported that IGFBP-6 delayed replicative senes-
cence of human fibroblast. IGFBP-6 is known to be up-regulated by retinoic acid in several types 
of tissue. However, the effect of retinoic acid (RA) induced IGFBP-6 on cellular senescence in 
NHKs was not fully understood. We investigated the effects of retinoic acid on IGFBP-6 expression 
and stress-induced premature senescence of NHKs. RA elevated IGFBP-6 expression in NHKs in 
dose-dependent manner. RA reduced p21 proteins and SA-beta-galactosidase activity induced by 
H2O2. RA prevented cellular senescence induced by oxidative stress. We hypothesized that the 
prevention of premature senescence by RA was due to IGFBP-6 elevation. To elucidate the hypoth-
esis, IGFBP-6 was knocked-down before RA treatment. As expected, retinoic acid was not able to 
prevent premature senescence in IGFBP-6 knocked-down keratinocyte. In this study, we revealed 
that RA can prevent premature senescence induced by oxidative stress via up-regulating IGFBP-6 
expression. These data suggest that retinoic acid prevents epidermal aging against external stress.   
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Smad7 levels play a causal role in anti-fibrosis
G Han, B Fan, Q Zhang and X Wang University of Colorado Anschutz Medical Campus, 
Aurora, CO
TGFβ is a potent fibrotic factor but anti-TGFβ therapy has not shown its efficacy in fibrotic diseases 
in humans. Fibrotic skins in systemic sclerosis (SSc) patients also show increased Wnt signaling. 
Smad7, a TGFβ antagonist, has been reported to be reduced in skin fibrotic diseases such as SSc 
and keloids, but it is unknown if reduced Smad7 is sufficient to contribute to the pathogenesis of 
fibrosis. We studied fibrotic formation in TGFβ1 transgenic mice with or without germline Smad7 
deletion or epidermic Smad7 overexpression. Mice overexpressing human TGFβ1 targeted by the 
keratin K5 promoter (K5.hTGFβ1) develop a severe autoimmune disorder and fibrosis in the skin and 
upper digestive tract in aged mice. Further, we bred K5.hTGFβ1 mice with germline heterozygous 
Smad7 (Smad7+/-) mice (homozygous germline Smad7 deletion was embryonic lethal). K5.hTGFβ1/
Smad7+/- mice exhibited accelerated fibrosis in the skin in juvenile. K5.hTGFβ1/Smad7+/- skin also 
showed increased nuclear β-catenin in both epidermis and dermis, consistent with our previous 
finding that Smad7 antagonizes Wnt signaling via inducing β-catenin degradation. Conversely, when 
breeding K5.hTGFβ1 mice with K5.Smad7 mice expressing Smad7 transgene expression in keratino-
cytes, inflammation and fibrosis were completely blocked. Then, we produced recombinant human 
Smad7 proteins with a Tat-tag (Tat-Smad7) that rapidly enter into cells. Tat-Smad7 subcutaneous 
injection to K5.hTGFβ1 mice alleviated skin inflammation and fibrosis. Our data suggest that loss 
of endogenous Smad7 contributes to fibrosis associated with activation of TGFβ and Wnt, whereas 
epidermal Smad7 overexpression blocks keratinocyte-produced inflammatory/fibrotic factors. Thus 
Smad7 could be a potential agent for fibrosis therapy by affecting both the epidermis and the dermis.   
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A rhamnose derivative to protect the dermal epidermal junction from aging
M Frechet,1 L Valenti,2 P Markioli,2 J Bliaux2 and J Nicolaÿ1 1 Exsymol, Monaco, Monaco and 
2 SEDIFA Laboratoire, Monaco, Monaco
The dermal epidermal junction (DEJ) is a highly specialized structure playing a crucial role in the 
maintenance of structural and mechanic properties of the skin. Collagens type IV and VII, collagen 
XVII, laminins and the proteoglycan perlecan are the main DEJ constituents, which are produced 
either by fibroblasts and/or keratinocytes. Intrinsic aging is associated with a decreased expression 
of some of these DEJ constituents, that likely causes fragility and DEJ characteristic age-related-flat-
tening. Expression of a α-L-rhamnose-recognizing lectin by keratinocytes and fibroblasts suggests 
that rhamnose is a regulator in DEJ formation. We have thus investigated the ability of rhamnose 
to modulate DEJ constituent’s expression. To improve rhamnose efficacy in vivo, it was associated 
with Methylsilanetriol (MTS), a vehicule molecule endowed with cytostimulating and connective 
tissue-structurating properties. The Rhamnose-MTS complex (R-S) properties were determined by 
immunofluorescence monitoring of the expression of several DEJ-specific proteins in living human 
skin explants. We found that R-S stimulates Collagen IV and Collagen VII expression by fibroblasts. 
Stimulation was higher than with rhamnose alone. Moreover, Laminin 5 (synthesized by kerati-
nocytes) and Perlecan expression was also augmented by R-S. Electronic microscopy analysis 
confirmed that R-S induced the formation of a thicker and better-organized DEJ. Altogether, these 
results strongly support the usefulness of the rhamnose derivative to fight against aged-induced 
alterations of DEJ.    
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Combination of pemphigus foliaceus IgG monoclonal antibodies (mAbs) promotes desmoglein 
1 clustering
K Yoshida,1 K Ishii,1 A Shimizu,1 M Yokouchi,2,3 JR Stanley4 and A Ishiko1 1 Dermatology, 
Toho University School of Medicine, Tokyo, Japan, 2 Dermatology, Keio University School 
of Medicine, Tokyo, Japan, 3 Dermatology, Tokyo Electric Power Co. Hospital, Tokyo, Japan 
and 4 Dermatology, University of Pennsylvania, Philadelphia, PA
Pemphigus foliaceus (PF) is an autoimmune blistering disease caused by autoantibodies against 
desmoglein1 (Dsg1). PF sera contain polyclonal antibodies which are a heterogeneous mixture of 
pathogenic and non-pathogenic monoclonal antibodies (mAbs) against Dsg1. These mAbs were 
obtained as single chain variable fragment (scFv) by antibody phage display then cloned as full 
length IgG. We analyzed the effect of these mAbs, individually and mixed together, on blister 
formation and sublocalization of desmosomal molecules in an organ culture human skin injection 
assay. A single pathogenic anti-Dsg1 IgG mAb caused a subcorneal blister in 22-24 hours and 
immunofluorescence showed the IgG mAb deposited linearly at cell surfaces on epidermis. When 
injected as a combination of a pathogenic and a non-pathogenic anti-Dsg1 IgG mAb, IgG deposits 
and Dsg1 localization showed an aberrant granular pattern. This Dsg1 clustering only occurred 
with divalent mAbs but not with monovalent scFvs indicating that it is caused by cross-linking of 
Dsg1. Most importantly, at least one pathogenic mAb in combination was needed to induce blister 
formation and Dsg1 clustering. In addition, immunofluorescence in skin biopsies of PF patients 
showed the partly granular distribution of IgG deposit in 4 out of 5 perilesional skin samples. These 
findings indicate that, although an individual non-pathogenic anti-Dsg1 IgG is not sufficient to cause 
a blister, together with pathogenic mAbs, it promotes dsg1 clustering which may be synergistic in 
causing a pathogenic effect. The findings also imply that pathogenic antibodies may be required 
for blister formation in PF patients.    
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Reduced autophagy in skin aging and positive regulation by a saponin-rich asparagus extract
D Imfeld,1 R Voegeli,1 P Boya2 and E Seco2 1 Personal Care R&D, DSM Nutritional Products 
Ltd, Kaiseraugst, Switzerland and 2 CIB, Consejo Superior de Investigaciones Cientificas, 
Madrid, Spain
Homeostasis in living cells requires replacement of aged components. Removal of most damaged 
intracellular proteins up to whole organelles is mediated by autophagy which comprises lysosomal 
degradation. However a decrease in autophagic activity has been observed during aging in several 
studies. Reduced autophagy can lead to an inadequate accumulation cellular waste that provokes 
increased oxidative stress and inflammation. Therefore rebalancing autophagy could represent a 
new strategy against accelerated aging. The idea of our work was to find out if reduced autophagy 
is part of the skin aging process and if imperfect skin appearance could be improved via stimulation 
of autophagy. In-vitro we demonstrated that the autophagy marker LC3 was reduced in fibroblasts 
from older donors (62y vs 28y) and was inversely correlated to senescence. However the stimulation 
of autophagy by in-vitro treatment positively correlated with reduced senescence. Therefore we 
suggested autophagy as a biological target mechanism for delaying skin aging. An in-vitro screening 
for stimulation of LC3 expression led us to an asparagus peel extract rich in saponins. We assumed 
that the saponins were the active component and did the in-vitro autophagy assay both with pure 
saponin and extract. In addition western blot analysis in presence of protease inhibitors showed an 
increase of LC3 lipidation (LC3-II) indicating an enhanced autophagic flux. The asparagus extract 
was further tested on UV-irradiated skin explants with positive effects on collagen quantity (+5%, 
p<0.05) together with a reduction of oxidized proteins (- 62%, p<0.05). Finally a double-blind, 
placebo- controlled trial on female volunteers with echographic, and SIAscope measurements 
showed an improved collagen density (+7%, p<0.05) and improved dermal thickness (+8%, p=0.07) 
after 56 days treatment. We conclude that reduced autophagy may be involved in skin aging and 
stimulation of autophagy, in our study by saponin-rich asparagus extract, could help to delay the 
signs of skin aging.    
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A novel truncated KIT in mastocytosis mast cells
I Chan and MD Tharp Dermatology, Rush University Medical Center, Chicago, IL
Auto-activating mutations of KIT are associated with mastocytosis. KIT encodes for the stem cell 
factor receptor which is essential for the growth and development of mast cells. KIT consists of an 
extracellular stem cell factor (SCF) binding domain, an intracellular juxtamembrane domain (JMD), 
a tyrosine kinase domain and a C-terminus. Previous studies have shown that point mutations in 
JMD, such as V560G, and the kinase catalytic site, such as D816V, result in the activation of KIT, 
and auto-activation of KIT is the main mechanism leads to the development of mastocytosis. Upon 
the classification of KIT mutation patterns in mastocytosis lesions, we have found a novel truncated 
KIT in an adult patient with mastocytosis. The patient expresses a full length, normal KIT in the 
peripheral blood lymphocytes, but a truncated KIT in lesional skin. The truncated KIT retains the 
SCF binding domain, the kinase catalytic site and C-terminus, but lacks the kinase ATP binding 
region. Histochemical staining showed that skin mast cells are highly reactive to a polyclonal 
antibody against phospho-KIT, suggesting the truncated KIT is phosphorylated in the mastocytosis 
mast cells. To further characterize the truncated KIT function, we have cloned it into the mam-
malian expressive vector pFRT/lacZeo and transfected into the U937 cell line by electroporation. 
Western blot hybridization using the polyclonal antibody against phosphor-KIT detected a 32 kD 
phosphor-KIT in transfected cell extracts, but not in non-transfected cells. These results indicate 
that the truncated KIT is phosphorylated. Since the C-terminus of KIT interacts with transmembrane 
proteins and cooperates with various signaling complexes, we hypothesize that truncated KIT may 
activate growth signaling pathways and promote uncontrolled mast cell growth in mastocytosis. 
This finding may represent a novel mechanism of KIT function in the development of mastocytosis 
with an emphasis on the function of the C-terminus.    
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Inducible basal keratinocyte-specific knockout of the LAMA3 gene: More than another model 
for epidermolysis bullosa
MM Aumailley, G Grimberg, M Pesch and H Qu Medical Faculty, University of Cologne, 
Cologne, Germany
We recently created a new inducible transgenic mouse model (Lama3fl/fl / K14-Cre-ERT mouse), in 
which the gene coding for the laminin alpha3 chain (Lama3) is switched off at chosen time point 
and location specifically in basal keratinocytes of the skin and mucosae. The model is viable and 
permits to examine the molecular and cellular consequences that are triggered by the loss of the 
laminin alpha3 chain. The laminin alpha3 chain associates intracellularly with the laminin beta3 
and gamma2 chains to form laminin-332, the most abundant laminin heterotrimer in the basement 
membrane of the skin. Laminin-332 is particularly important for anchorage of the epidermis to the 
dermis, as pointed out by previous studies on inherited bullous (blister-forming) skin diseases. In 
addition, laminin-332 controls the behavior of basal keratinocytes by interacting with receptors 
anchored in their surface, and it is assumed to be essential for maintaining the functional properties 
of basal keratinocytes and the integrity of the dermal-epidermal junction. The mouse model that we 
have generated recapitulates the characteristic clinical features of junctional epidermolysis bullosa, 
enabling to dissect disease-causing mechanisms, to identify compensatory pathways, and to test 
therapeutic approaches. Moreover, the turnover of the skin basement membrane can be precisely 
assessed as a function of age and anatomical location.    
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Loss of the laminin-332 α3IIIa domain impairs keratinocyte migration in vitro
JY Wang, HK Duggireddy Lakshmireddy and MP Marinkovich Dermatology, Stanford 
University School of Medicine, Stanford, CA
Various domains of the basement membrane protein laminin-332 are known to play key roles in 
the development of normal epithelia and squamous cell carcinoma, but the role of the N-terminal 
IIIa domain of the α3 chain in these processes is unknown. Genetic truncation of this domain in 
the laryngo-onycho-cutaneous syndrome, a subtype of junctional epidermolysis bullosa, results 
in chronic granulation tissue and poor wound healing without marked skin fragility, although the 
pathogenic mechanism is not clear. To better understand the biology of the α3IIIa domain, a poly-
clonal antibody was generated against purified recombinant α3IIIa protein. The antibody was able to 
detect the presence of the IIIa domain in the dermal-epidermal junction of normal human skin, and 
using this antibody we demonstrated the physiologic cleavage of the IIIa domain from the full-length 
α3 chain in vitro. To determine the function of this domain in cell behavior, LAMA3-null human 
keratinocytes were infected with the full-length LAMA3 gene (WT) or the LAMA3 gene lacking the 
IIIa domain (ΔIIIa). Both the WT and ΔIIIa cells exhibited comparable levels of trimeric laminin-332 
deposition in the extracellular matrix and proper formation of focal adhesion and hemidesmosomal 
structures. ΔIIIa cells did not demonstrate a greater propensity for detachment from tissue culture 
substrate. However, migration of ΔIIIa cells was significantly impaired compared to WT cells, with 
ΔIIIa cells achieving 50% less closure of a scratch assay defect than WT cells by 72 hours (p<0.05). 
Single-cell live imaging studies further revealed significantly diminished migration velocity and 
path directness by ΔIIIa cells. Our findings thus far suggest a potential role for the α3IIIa domain in 
mediating keratinocyte migration, which is critical for both wound re-epithelialization and epithelial 
tumor invasion. In vivo studies using the ΔIIIa cells and the α3IIIa antibody are currently in progress 
to clarify the role of the α3IIIa domain in epidermal repair and tumorigenesis.    
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The absence of functional type VII collagen in RDEB patients causes faculty regulation of 
TGF-beta and profound skin scarring
X Wang, Y Hou, J Wang, DT Woodley and M Chen Dermatology, University of Southern 
California, Los Angeles, CA
Patients with recessive dystrophic epidermolysis bullosa (RDEB) develop multiple skin wounds that 
heal with extensive scarring, contractures and mitten deformities. RDEB is caused by mutations 
in the gene that encodes type VII collagen (C7). We showed previously that topical application 
of recombinant C7 to murine skin wounds decreased the expression of fibrogenic transforming 
growth factor (TGF)-β2 and increased the expression of anti-fibrogenic TGF-β3, accompanied by the 
reduced expression of several fibrosis markers, such as connective tissue growth factor (CTGF) and 
α-SMA -positive myofibroblasts. In this study, we used skin samples and primary keratinocyte and 
fibroblast cultures from 10 RDEB patients and normal humans to compare the expression of TGF-β 
isoforms and various genes involved in TGF-β-induced fibrosis signaling pathways. Immunostaining 
of skin samples from RDEB patients revealed increased expression of pro-fibrogenic TGF isoforms 
(TGF-β1 and TGF-β2), canonical TGF-β1 signaling (phospho-Smad2/3 and CTGF), non-canonical 
TGF-β1 signaling (p-AKT), and selective extracellular matrices (collagen I, tenascin and fibronectin). 
Immunoblot analysis of cellular extracts or conditioned media showed the upregulation of TGF-
β1, TGF-β2, TGF-β receptor 1, p-Smad2/3, CTGF, and p-AKT in RDEB keratinocytes and p-AKT, 
periostin, Slug and collagen I in RDEB fibroblasts. Re-expression of C7 in RDEB fibroblasts or 
keratinocytes via a lentiviral vector or supplementing RDEB cells with recombinant C7 decreased 
the expression of TGF-β1, TGF-β2, TGF-β receptor 1, p-Smad2/3, CTGF, p-AKT, periostin, Slug and 
collagen I. Likewise, reduction of C7 in normal skin cells via siRNAs led to increased expression 
of these pro-fibrotic markers. In conclusion, loss of C7 in RDEB patients up-regulates pro-fibrotic 
TGF-β signaling and induces a distinct pro-fibrotic gene expression program. Our data provides 
new insights into the molecular mechanisms of RDEB scarring.    
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Type VII collagen binds pro-fibrogenic TGF beta isoforms: Implications for scarring in RDEB 
patients and scarless wound healing
J Cogan, L Moy, K Kim, DT Woodley and M Chen Dermatology, University of Southern 
California, Los Angeles, CA
Type VII collagen (C7), composed of a central triple helical domain (TH) flanked by non-helical 
domains, NC1 and NC2, is the major component of anchoring fibrils that mediate epidermal-dermal 
adherence. The NC1 domain contains motifs homologous to other adhesive molecules including 
nine fibronectin type III-like repeats (FNIII), the A domain of von-Willebrand factor (VWF-A), and 
cartilage matrix protein (CMP). In this study, we evaluated the binding of C7 to various growth 
factors using recombinant human C7 and NC1 and refined the binding sites within the NC1 domain 
using a panel of NC1 deletion mutant proteins and a solid-phase ligand, antigen-to-antigen affinity 
assay. We found that both NC1 and C7 strongly bind to transforming growth factor beta isoforms 
(TGF-β1, TGF-β2 and TGF-β3) and platelet-derived growth factor in a dose-dependent manner, 
but not transforming growth factor alpha or epidermal growth factor. Heat inactivated C7 and NC1 
failed to bind to TGF-β. TGF-β bound to C7 with greater affinity than any other extracellular matrix 
macromolecules tested. Neither laminin nor a C7 interacting protein, fibronectin, interfered with 
the binding of TGF-β to C7. TGF-β1 competed with TGF-β2 for binding to C7. Using a battery of 
bacterial fusion proteins with NC1, we have mapped the TGF-β binding sites to multiple FNIII within 
NC1. We conclude that FNIII within NC1 is a potent ligand for TGF-β isoforms. The binding of C7 
to pro-fibrogenic TGF-β may play an important role in C7’s ability to accelerate wound healing, 
with less scar formation and the absence of functional C7 may promote scarring in patients with 
recessive dystrophic epidermolysis bullosa. Our finding that C7 has the ability to bind TGF-β, 
and that FNIII within NC1 are responsible for this binding, may have important implications for 
promoting scarless wound healing and the development of C7 subdomains as biomimetic materials 
for tissue engineering.    
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Contact-dependent activation of EphA2 is required for keratinocyte differentiation and 
recruitment of the phosphoinositol phosphatase SHIP2
BE Perez White, N Kaplan and S Getsios Dermatology, Northwestern University, Chicago, IL
EphA receptors are members of the largest family of receptor tyrosine kinases and promote keratino-
cyte differentiation when engaged by ephrin-A ligands on adjacent cells. The specific receptor sub-
type and signaling complexes elicited by these promiscuous membrane receptor-ligand interactions 
remain unclear. EphA2 is a good candidate for mediating these differentiation responses to ephrins as 
it undergoes contact-dependent activation in keratinocytes and exhibits altered expression patterns 
in psoriasis and skin cancers where differentiation is impaired. The aims of this study were to: (1) 
determine if EphA2 is mandatory for contact-dependent differentiation in normal human epidermal 
keratinocytes (NHEKs) and (2) identify signaling molecules associated with EphA2 after stabilization 
of cell-cell contacts by a calcium-switch. To determine its requirement for differentiation, EphA2 
was silenced by lentiviral shRNA delivery in NHEKs. Induction of suprabasal epidermal proteins 
(keratin 10, desmocollin 1, desmoglein 1, loricrin, and occludin) was impaired in EphA2-deficient 
NHEKs following a calcium-switch. This differentiation defect was reversed by restoring EphA2 lev-
els with a silencing-resistant murine variant of this receptor. In contrast, a truncation mutant lacking 
the entire cytoplasmic domain of EphA2 or overexpression of the closely related EphA1 failed to 
rescue differentiation. To identify effector proteins of EphA2 that relay downstream signaling during 
differentiation, co-IP of the native receptor was performed in NHEKs. EphA2 associated with Akt 
prior to its activation and this interaction was lost upon stabilization of cell-cell contacts. Following 
contact-dependent activation, EphA2 cyclically recruited SHIP2; this lipid phosphatase negatively 
regulates PI3K-Akt signaling and promotes surface stabilization of EphA2. These findings illustrate 
the dynamic signaling events associated with EphA2, a receptor that executes a requisite response 
to cell-cell contact that drives proper keratinocyte differentiation.    
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E-cadherin phosphorylation promotes cell-cell adhesion and inhibits motility in A431D epi-
dermoid carcinoma cells
AE McEwen,1,2 MT Maher,1,2 R Mo1 and CJ Gottardi1 1 Medicine, Northwestern University, 
Chicago, IL and 2 Driskill Graduate Program, Northwestern University, Chicago, IL
Intercellular adhesion in epithelia is largely mediated by a complex composed of the transmem-
brane protein E-cadherin, which mediates Ca++ dependent homophilic interactions, and associated 
catenins, which link to the underlying cytoskeleton. It has long been appreciated that E-cadherin is 
highly phosphorylated within its β-catenin binding region, and that this phosphorylation increases 
its affinity for β-catenin in vitro. We have recently identified key serines in the β-catenin binding 
domain responsible for most radioactive phosphate incorporation. These serines are required for 
binding to β-catenin and the mutual stability of both E-cadherin and β-catenin. In this study, we 
use the pan-cadherin null cell line A431D, derived from vulvar carcinoma, to investigate the effects 
of E-cadherin phosphorylation on cell-cell adhesion and motility. Cells reconstituted with a phos-
phodeficient (S>A) E-cadherin exhibit minimal cell-cell adhesion due to enhanced endocytosis and 
degradation through a lysosomal compartment. Conversely, negative charge substitution at these 
serines (S>D) antagonizes cadherin endocytosis and restores WT levels of adhesion. Moreover, S>A 
E-cadherin fails to inhibit cell motility, while S>D E-cadherin inhibits cell motility similarly to WT 
E-cadherin. Together, these data suggest that E-cadherin phosphorylation is largely constitutive and 
integral to cadherin-catenin complex formation, surface stability and function.    
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Deletion of the glucocorticoid receptor inhibitor FKBP51 unexpectedly prevents development 
of glucocorticoid-induced cutaneous atrophy via Akt activation
G Baida,1 P Bhalla,1 H Chen,2 W Shou,2 E Sanchez3 and I Budunova1 1 Dermatology, 
Northwestern University, Chicago, IL, 2 Wells Center for Pediatric Research, Indiana 
University, Indianapolis, IN and 3 Physiology & Pharmacology, University of Toledo College 
of Medicine, Toledo, OH
FK506-binding protein 51 (FKBP51) is a known co-chaperone and regulator of the glucocorticoid 
receptor (GR), which attenuates its activity by preventing nuclear translocation. We and others 
showed previously that FKBP51 is one of the central GR targets in skin. However, its role in clinical 
effects of glucocorticoids in skin has not been studied. Here, we used FKBP51 knockout (KO) animals 
to determine the role of FKBP51 in the major adverse effect of glucocorticoids, skin atrophy. We 
discovered that adult FKBP51 KO mice have significant skin abnormalities, including epidermal 
hyperplasia and frequent follicular cysts, suggesting an important role of FKBP51 in epidermis 
maintenance and hair development. Importantly, FKBP51 KO animals were much more resistant to 
skin atrophy induced by chronic treatment with glucocorticoid fluocinolone acetonide (FA), which 
coincided with protection of CD34+ keratinocyte stem cells in hair follicle bulge. Paradoxically, 
despite the lack of inhibitory FKBP51, FA activation of some GR target genes in epidermis was 
attenuated, even though their basal expression was higher in KO mice. Among them was REDD1 
which we have recently identified as a marker of steroid-induced epidermal atrophy. GR activation 
by glucocorticoids results in both genomic and non-genomic effects, including the inhibition of 
Akt, a major mediator of proliferative signaling in the skin. It is known that FKBP51 negatively 
regulates Akt phosphorylation and activity. Importantly, we found drastic increases in Akt-Ser473 
phosphorylation in the epidermis of both vehicle- and FA-treated FKBP51 KO mice compared to 
WT animals. Overall, our results suggest that Akt activation is at least partially responsible for the 
resistance of FKBP51 KO mice to atrophic effects of topical glucocorticoids. Work is supported by 
RO1CA118890 and Foglia family foundation grant (to IB).    
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Notch signaling may be involved in the abnormal differentiation of epidermal keratinocytes 
in psoriasis
T Mabuchi,1 S Takekoshi,2 T Ota,1,2 T Takagi,2 K Kitatani,2 K Toriumi,2 T Kojima,1,2 
M Kato,1 N Ikoma1 and A Ozawa1 1 Department of Dermatology, Tokai University School 
of Medicine, Isehara, Japan and 2 Department of Cell Biology, Division of Host Defense 
Mechanism, Tokai University School of Medicine, Isehara, Japan
Localization of each keratin isoform differs among epidermal layers. Proliferating basal cells synthe-
size keratin 14 (K14) and suprabasal cells express keratin 10 (K10) in normal skin. Notch signaling 
is essential for keratinocyte differentiation. Notch1 is expressed in all epidermal layers, Notch2 in 
the basal cell layer and Notch3 in basal cell and spinous cell layers in normal epidermis. We inves-
tigated keratins (K14 and K10) and Notches (1, 2, 3 and 4) using immunohistochemistry in psoriatic 
skin (n=30) and normal skin (n=10). In normal skin, K14 and K10 were discretely observed in the 
basal cell layer and suprabasal layer, respectively. In psoriatic skin, K14 was expressed in the pan 
epidermal layer while it and K10 were co-expressed in some middle suprabasal layer cells. Notch1, 
2, 3, and 4 localized in all epidermal layers in normal skin. In psoriatic skin, Notch1, 2, 4 mainly 
localized in suprabasilar layers and Notch3 is in pan epidermal, suprabasilar and basilar layers. 
Protein and mRNA of Notch 1, 2 and 3 isoforms decreased in psoriatic epidermis compared with 
normal epidermis. This suggests that decrements in these Notch molecules might cause aberrant 
expression of K10 and 14 leading to anomalous differentiation of the epidermis in psoriatic lesions.   
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Expression and regulation of the scavenger receptor OLR1/LOX1 in mammalian skin
IM Naglereiter, M Parvardeh, MS Narzt, M Ghannadan-Schuch, S Karner, M Mildner, 
E Tschachler and F Gruber Dermatology, Medical University of Vienna, Vienna, Austria
Damage exerted by oxidant stress in the skin and other tissues accumulates over the lifespan, and is 
manifested in enhanced levels of oxidatively modified lipids and proteins or as advanced glycation 
endproducts (AGE). Lipid oxidation within the skin is correlated to ageing and age-related pathol-
ogies that develop upon solar exposure such as actinic elastosis. Molecules showning a damage 
assoicated molecular pattern (DAMP), as oxidized lipids do, can be taken up by cells and induce 
signaling by interaction with receptors. Lectin-like oxidized LDL receptor-1 (OLR1/LOX1) is a 
receptor that recognizes, oxidized lipids/proteins, dead cell remnants, and mediates oxidant stress 
induced signaling. Most of the evidence comes from atherosclerosis research, and OLR1 was so 
far not described in the skin which also is a locoation where oxidized lipids and modified protein 
accumulate after stress and in aging. Preliminary studies in human fibroblasts showed that OLR1 
expression is increased in stress induced senescence. In this project we investigated the expression 
of OLR1 in the skin of mice and humans, and its regulation by oxidative stress. Murine back skin 
and ears were examined with immunohistochemistry and immunofluorescence microscopy for 
expression of OLR1 and its distribution within the skin. OLR1 was found expressed, with decreasing 
intensity, in sebaceous glands, cells tenatively identified as a mast cells, keratinocytes and dermal 
fibroblasts. Expression of OLR1 was verified on mRNA level in cultured fibroblasts, keratinocytes 
and bone marrow derived mast cells. Application of a stress protocol of two consecutive exposures 
to UVA, hydrogen peroxide or oxidized phospholipids led to significant induction of OLR1 expres-
sion. This is the first description of the scavenger receptor OLR1 in cells of the skin and this allows 
now to study the functional contribution of OLR1 to the stress responses and aging of the skin.   
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Amphiregulin supports G2/M progression via FoxM1 and inhibits differentiation in human 
keratinocytes
SW Stoll,1 WR Swindell,1 A Johnston1 and JT Elder1,2 1 Dermatology, University of Michigan, 
Ann Arbor, MI and 2 Ann Arbor VA Hospital, Ann Arbor, MI
The regulatory network controlling the growth and differentiation of epidermal keratinocytes (KC) 
remains incompletely understood. We have reported that autocrine proliferation of human KC is 
strongly inhibited by Tet-inducible shRNA silencing of the EGF-like growth factor amphiregulin 
(AREG), accompanied by a substantial increase in cells with ≥4n DNA content. RNA-seq-based 
transcriptome analysis revealed that Tet-mediated AREG silencing significantly (>2-fold, FDR 
<.05) altered the expression of 2310 genes (1231 up, 1089 down), 618 of which (204 up, 414 
down) were not reversed by subsequent addition of EGF. A significant proportion of the irreversibly 
down-regulated genes featured upstream binding sites recognized by FoxM1, a key transcription 
factor involved in the G2/M checkpoint (FDR =5.2×10-7). Genes up-regulated by Tet overlapped 
significantly (p <0.001) with genes involved in Ca++-mediated KC differentiation, with enrichment 
for genes involved in homophilic cell adhesion (cadherins), nucleosome assembly (H2 histones), 
and immune response (C3, IFIT2, IFIT3). AREG downregulation significantly (p <0.001) preceeded 
downregulation of FoxM1 and its target genes, followed by reduction in mitoses. As quantitatively 
assessed by flow cytometry, KC growth in AREG knockdown cells was strongly inhibited even in 
the presence of 100 ng/ml recombinant AREG (8.3 +/- 0.9% of control, mean +/- SEM, n=3). In 
contrast, constitutive expression of FoxM1 in AREG knockdown cells markedly restored cell growth, 
whether in the presence or absence of added AREG (63.9 +/- 4.8% and 41.5 +/- 11.1% of control, 
respectively, p <0.005 vs. AREG shRNA for both). FoxM1 overexpression also markedly reduced the 
number of cells with ≥4n DNA content and restored expression of the FoxM1 target genes AURKB 
and CENPA (p <0.01, n=4). Taken together, our data indicate that AREG allows G2/M transit in 
KC by supporting a FoxM1-dependent transcriptional program, while repressing differentiation via 
inhibition of key KC differentiation genes.    
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Regulation of ECM proteins by microRNA
RP Khusial and U Santhanam Global R&D, Avon Products Inc, Suffern, NY
microRNAs (miRs) are a class of short noncoding RNA molecules that are major post-transcriptional 
regulators of gene expression. It is established that one miR can regulate several mRNA targets and 
one mRNA can, in turn be regulated by several discrete miRs. miRs have been demonstrated to 
regulate mRNA via complementary binding to their cognate targets. The human genome encodes 
over 1000 miRs and collectively they can potentially regulate approximately 60% of the protein 
coding genes. Considering the importance of the miRs in regulating gene expression, it is very likely 
that the expression of skin matrix proteins such as collagen elastin and fibrillin, may be regulated by 
activity of miRs. However, identification of specific miRs that regulate extracellular matrix proteins 
in skin cells is a largely uncharted research area. Our work has identified members of the miR-29 
family, miR-29a and miR-29b, that function as negative regulators of collagen, elastin and fibrillin 
in skin cells. We have also demonstrated that relative levels of miR-29a and miR-29b increase with 
age in skin cells, which can contribute to a decline in collagen, elastin and fibrillin expression and 
thereby contribute to the appearance of aging signs such as lines, wrinkles and loss of firmness. 
Theoretically therefore, down-regulation of these miRs could allow for increased expression of their 
target skin matrix proteins in aging skin cells. Additionally, we have examined the consequence 
of UV exposure on miR-29 levels in skin cells. In sum, this work describes a novel role of miRs in 
regulating extracellular matrix proteins in skin.    
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Desmoglein-2 activates mitogenic signaling by modulating scaffolding proteins in lipid rafts
KP McGuinn, D Brennan-Crispi, F Cooper, JK Wahl and MG Mahoney Dermatology and 
Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA
Lipid rafts are highly dynamic, detergent-resistant membrane microdomains densely packed with 
cholesterol, sphingolipids and scaffolding proteins. One such protein, caveolin, regulates cell com-
munication by compartmentalizing and interacting with signaling proteins. Alterations in lipid 
raft microenvironment can initiate signaling pathways affecting cellular function and behavior. 
We previously showed that the desmosomal cadherin Dsg2 associates with Cav-1, providing a 
mechanism for regulating mitogenic signaling and contributing to malignant transformation and 
skin tumor formation. Here we show evidence that Dsg2 activates cell signaling by modulating 
lipid rafts. Knockdown of Dsg2 by shRNA in HaCaT cells did not alter the total level of Cav-1 but 
instead, increased Cav-1 mobilization into membrane raft fractions. Cav-1 is a negative regulator 
of the proto-oncogene Src and the Ras-p42/44 mitogen-activated kinase cascade. In the absence of 
Dsg2, we observed an increase in Src localization into lipid rafts with a concomitant reduction in 
activated Src. Disruption of lipid rafts by filipin III or MβCD shifted Cav-1 to the non-raft fractions 
and activated several signaling pathways, including Src, Ras/MEK/Erk, and Stat3. In the absence of 
Dsg2, more Cav-1 was retained in the raft fractions after MβCD treatment and activation of these 
signaling pathways was attenuated. Interestingly, Dsg2-expressing cells were more susceptible to 
disruption by these cholesterol-chelating agents. Taken together, these results suggest that Dsg2 
may play an important role in regulating lipid raft composition and dynamics, thereby providing a 
mechanism for regulating cell signaling and survival.    
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Role of new α-catenin homologue - Catulin in skin development and wound healing
K Boddupally, C Cao and A Kobielak Otolaryngology - Head & Neck Surgery, USC, Norris 
Cancer Center, Los Angeles, CA
During development, epithelial tissues undergo rearrangements that require integration of signals 
from neighboring cells and the extracellular matrix (ECM). Vinculin and α-catenin are two related 
proteins that play crucial roles in those processes; the function of their recently characterized 
homologue catulin is still poorly understood. In our recently published data we started to unveil 
the role of this novel protein in squamous cell carcinoma migration and invasion. Here, we unveil 
the cellular and physiological function of catulin during mouse skin development. Using a catulin 
reporter mouse model established in our laboratory we showed that catulin is expressed in the 
epidermis during hair follicle development, later the expression is minimal in the epidermis but 
becomes stronger during hair follicle activation and also during wound healing. Our in vitro and in 
vivo data strongly support a model in which catulin mediates integrin signaling presumably acting 
as a scaffold for Rho GTPase and its downstream ROCK/Myosin signals (Rho-associated protein 
kinase). Since straight catulin KO that we generated is embryonically lethal we’ve developed a 
conditional knockout of catulin in embryonic skin to understand the functional significance of 
this protein. Our data indicate that ablation of catulin in the skin both during development affects 
skin morphogenesis and wound repair. Our data suggest that catulin plays important role in skin 
development and homeostasis by mediating ECM-integrin-Rho pathway signaling by acting as a 
scaffold for Rho complex distribution that results in proper spatial activation of signaling down-
stream from ROCK. Understanding how these cytoskeletal linkages are regulated in normal skin 
is a prerequisite to elucidating how defects in these processes lead to genetic disorders, defects in 
wound healing and skin cancers.    
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The effects of matrix laminin-511 in the growth of human squamous cell carcinoma in ani-
mal model
J Li, L Tang and M Zarei Dermatology and Cutaneous Surgery, University of Miami Miller 
School of Medicine, Miami, FL
The objective of this study was to examine the effects of laminin-511 (α5, β1, γ1) on human squa-
mous cell carcinoma (SCC) growth in vivo. Recent research has shown that the aggressive nature of 
malignant cells is regulated by their extracellular matrix environment. Laminin-511 has been found 
to be a major component of the basement membranes of epithelia and microvascular blood vessels 
and is thought to be one of the key proteins influencing cell behavior. Our previous study demon-
strated that laminin-511 is critical for SCC cell proliferation, migration and invasion, and is highly 
expressed in human SCC tumors as well. In this study, we have examined the effects of laminin-511 
in SCC tumor growth in vivo in tumor xenograft model. The human SCC-25 cells were transduced 
with lentiviral vectors which carry human laminin α5 chain short hairpin RNA (lenti-Lα5 shRNA) to 
block the mRNA expression of laminin-511 (about 80% knockdown). Subconfluent cultures of SCC 
cells stably transduced with lenti-Lα5 shRNA (SCC/Lα5), control shRNA (SCC/LUC) or their parental 
cells (SCC) were harvested. The cells were injected subcutaneously into the flanks of 7~8 week-old 
female athymic nude (Nu/Nu) mice, 10 mice for each group. Tumor growth was monitored every 
day. 7 weeks after injection, tumors grew from all injections of both SCC parental cells (10 out of 
10 injections) and SCC/LUC control cells (20 out of 20 injections), while only 11 tumors grow out 
of 18 injections of cells with laminin α5 knockdown (SCC/Lα5). Average tumor weight was 6mg 
for SCC/Lα5 cells compared with 48mg for parental SCC cells and 45mg for control SCC/LUC cells. 
Furthermore, tumors induced by SCC cell with Lα5 knockdown grow much smaller compared to 
two control SCC cell types. The data further support the concept that laminin-511 play important 
roles in SCC growth and may be useful for the diagnosis or treatment.    
   
